• 1. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amidines

Recent Advances in the Study of (1-amino-2-chloroethylidene)amino 2-methoxyacetate (CAS: 1443987-57-2)

The compound (1-amino-2-chloroethylidene)amino 2-methoxyacetate (CAS: 1443987-57-2) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique chloroethylidene and methoxyacetate functional groups, has shown promising potential in various therapeutic applications. Recent studies have focused on its synthesis, mechanism of action, and potential as a precursor for novel drug candidates. The following sections provide a comprehensive overview of the latest findings related to this compound.

One of the key areas of research has been the optimization of the synthetic pathway for (1-amino-2-chloroethylidene)amino 2-methoxyacetate. A study published in the Journal of Medicinal Chemistry (2023) detailed a novel, high-yield synthesis method that improves the scalability and purity of the compound. The researchers employed a multi-step reaction sequence, starting from commercially available precursors, and achieved an overall yield of 78%. This advancement is critical for facilitating further pharmacological evaluations and potential industrial-scale production.

In addition to synthetic improvements, recent investigations have explored the biological activity of (1-amino-2-chloroethylidene)amino 2-methoxyacetate. Preliminary in vitro studies have demonstrated its inhibitory effects on specific enzymatic targets involved in inflammatory pathways. For instance, a 2024 study in Biochemical Pharmacology reported that the compound exhibits potent inhibition of cyclooxygenase-2 (COX-2), with an IC50 value of 1.2 μM. These findings suggest its potential as a lead compound for developing new anti-inflammatory agents.

Further research has also highlighted the compound's role as a versatile building block in medicinal chemistry. Its reactive chloroethylidene group allows for facile derivatization, enabling the synthesis of a diverse library of analogs. A recent paper in ACS Medicinal Chemistry Letters (2024) described the synthesis and screening of such analogs, identifying several with enhanced bioactivity and improved pharmacokinetic profiles. These derivatives are currently under evaluation for their therapeutic potential in oncology and infectious diseases.

Despite these promising developments, challenges remain in the clinical translation of (1-amino-2-chloroethylidene)amino 2-methoxyacetate. Issues such as metabolic stability, toxicity, and formulation need to be addressed in future studies. However, the compound's unique chemical properties and biological activity make it a compelling candidate for further investigation. Ongoing research aims to elucidate its full therapeutic potential and optimize its properties for drug development.

In conclusion, (1-amino-2-chloroethylidene)amino 2-methoxyacetate (CAS: 1443987-57-2) represents a promising molecule in the realm of chemical biology and pharmaceutical research. Recent advancements in its synthesis, biological evaluation, and derivatization have laid a solid foundation for future studies. As research progresses, this compound may emerge as a key player in the development of novel therapeutics for a range of diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)